Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $24.05 USD
Change Today -0.05 / -0.21%
Volume 8.0K
NUTR On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

nutraceutical intl corp (NUTR) Key Developments

Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended March 31, 2015

Nutraceutical International Corporation reported unaudited consolidated earnings results for the second quarter and six months ended March 31, 2015. Net sales for the fiscal 2015 second quarter were $55.4 million compared to $54.9 million for the same quarter of fiscal 2014. For the second quarter of fiscal 2015, net income was $4.1 million, or $0.43 diluted earnings per share, compared to net income of $4.3 million, or $0.44 diluted earnings per share, for the same quarter of fiscal 2014. Income from operations was $6.738 million against $7.226 million a year ago. Income before provision for income taxes was $6.465 million against $6.876 million a year ago. Adjusted EBITDA was $10.006 million against $10.003 million a year ago. Net sales for the six months ended March 31, 2015 were $108.4 million compared to $106.4 million for the same period of fiscal 2014. For the six months ended March 31, 2015, net income was $7.4 million, or $0.77 diluted earnings per share, compared to net income of $8.5 million, or $0.86 diluted earnings per share, for the same period of fiscal 2014. Operating cash flow for the six months ended March 31, 2015 was $11.2 million compared to $10.8 million for the same period of fiscal 2014. The operating cash flow for the six months ended March 31, 2015, combined with existing cash, was primarily used to invest $4.2 million in purchases of property, plant and equipment, $2.4 million in purchases of common stock for treasury and to repay net borrowings of $5.0 million on the Company's revolving credit facility. Income from operations was $12.307 million against $14.123 million a year ago. Adjusted EBITDA was $18.814 million against $19.538 million a year ago.

Nutraceutical International Seeks Acquisitions

Nutraceutical International Corporation (NasdaqGS:NUTR) is looking for acquisitions. Bill Gay, Chairman and Chief Executive Officer said, "Our overall results for the second quarter of 2015 were an improvement over our first quarter results. Fiscal 2015 second quarter net sales growth of 1.0% was primarily the result of fiscal 2014 acquisitions and a slight increase in domestic sales. Â Unfortunately, international sales were impacted negatively by a stronger U.S. dollar and decreased orders from international customers. Out-of-stocks continue to be a key priority for management. We continue to focus on integrating the fiscal 2014 acquisitions and believe these efforts, along with other operational enhancements we have made, will lead to further improvements in our business by the latter part of calendar 2015."

Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended December 31, 2014; Provides Sales Guidance for the Fiscal 2015

Nutraceutical International Corporation reported unaudited consolidated earnings results for the first quarter ended December 31, 2014. Net sales were $53,044,000 compared to $51,550,000 a year ago. Income from operation was $5,569,000 compared with $6,897,000 a year ago. Income before provision for income taxes was $5,272,000 compared with $6,579,000 a year ago. Net income was $3,351,000 compared with $4,135,000 a year ago. Net income diluted per share was $0.35 compared with $0.42 a year ago. Adjusted EBITDA was $8,808,000 compared with $9,535,000 a year ago. Operating cash flow for the fiscal 2015 first quarter was $3.0 million compared to $5.5 million for the same period of fiscal 2014. The fiscal 2015 first quarter operating cash flow, combined with existing cash, was primarily used to invest $2.6 million in purchases of property, plant and equipment. The company's net sales growth of 2.9% was primarily the result of fiscal 2014 acquisitions. Non-acquisition net sales during the quarter were down slightly as a result of increased product out-of-stocks and some health food store market softness. Adjusted EBITDA decreased from the comparable fiscal 2014 quarter as a result of lower gross margins and increases in marketing, selling and distribution expenses, which came principally from the integration of fiscal 2014 acquisitions. The decrease in fiscal 2015 quarterly net income was primarily a result of increased amortization and depreciation expense relating to acquisitions and capital investments in equipment. The company expects operational synergies and further net sales growth from the fiscal 2014 acquisitions in the later part of 2015.

Nutraceutical International Corporation, Annual General Meeting, Jan 26, 2015

Nutraceutical International Corporation, Annual General Meeting, Jan 26, 2015., at 09:00 US Mountain Standard Time. Location: The Grand America Hotel. Agenda: To consider the election of two class II directors, each for a term of three years; to consider the ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending September 30, 2015; to consider the advisory vote to approve named executive officer compensation; and to consider the any other business that may properly come before the meeting or any adjournment of the meeting.

Nutraceutical International Corporation Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended September 30, 2014

Nutraceutical International Corporation reported unaudited consolidated earnings results for the fourth quarter and year ended September 30, 2014. For the quarter, the company reported net sales of $52,440,000 against $51,256,000 a year ago. Income from operations was $5,688,000 against $6,988,000 a year ago. Income before provision for income taxes was $5,291,000 against $6,652,000 a year ago. Net income was $3,433,000 or $0.35 per basic and diluted share against $4,136,000 or $0.42 per basic and diluted share a year ago. Adjusted EBITDA was $9,066,000 against $9,578,000 a year ago. For the year, the company reported net sales of $214,474,000 against $208,397,000 a year ago. Income from operations was $26,497,000 against $28,133,000 a year ago. Income before provision for income taxes was $25,076,000 against $26,773,000 a year ago. Net income was $15,889,000 or $1.62 per diluted share against $17,008,000 or $1.73 per diluted share a year ago. Adjusted EBITDA was $38,232,000 against $38,048,000 a year ago. Operating cash flow for the fiscal year ended September 30, 2014 was $20.0 million compared to $26.8 million for fiscal 2013. The operating cash flow for the fiscal year ended September 30, 2014, combined with net borrowings of $10.5 million and existing cash, was primarily used to invest $16.4 million in acquisitions of natural product businesses, $11.3 million in purchases of property, plant and equipment and $5.1 million in purchases of common stock for treasury. Net sales growth of 2.9% was comparable to fiscal 2013 net sales growth of 4.0%. Fiscal 2014 growth came primarily from acquisitions completed during the last two fiscal years. Adjusted EBITDA for fiscal 2014 increased slightly despite the increased costs and internal time dedicated to recent acquisitions. The decrease in fiscal 2014 net income was primarily a result of increased amortization and depreciation expense relating to acquisitions and capital investments made to enhance future growth and reduce costs, including a substantial investment in new laboratory facilities and equipment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NUTR:US $24.05 USD -0.05

NUTR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aceto Corp $23.38 USD -0.24
GNC Holdings Inc $42.33 USD +0.83
Hain Celestial Group Inc/The $67.59 USD +0.45
USANA Health Sciences Inc $125.16 USD -0.57
Vitamin Shoppe Inc $35.15 USD +0.55
View Industry Companies
 

Industry Analysis

NUTR

Industry Average

Valuation NUTR Industry Range
Price/Earnings 15.7x
Price/Sales 1.1x
Price/Book 1.5x
Price/Cash Flow 13.0x
TEV/Sales 0.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NUTRACEUTICAL INTL CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.